Tower Research Capital »

Pelthos Therapeutics shares owned by Tower Research Capital

Quarter-by-quarter ownership of Pelthos Therapeutics shares owned by Tower Research Capital from 13F filings

Historical chart of Tower Research Capital investment in Pelthos Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Pelthos Therapeutics held by Tower Research Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pelthos Therapeutics by Tower Research Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $23k 827 28.00

More positions owned by Tower Research Capital

Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
Ishares Tr 1 3 Yr Treas Bd (SHY)
Meta Platforms Cl A (META)
Broadcom (AVGO)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Direxion Shs Etf Tr Dly Scond 3xbu (SOXL)
Alphabet Cap Stk Cl A (GOOGL)
J P Morgan Exchange Traded F Ultra Shrt Etf (JPST)
Vanguard Instl Index 0-3 Mo Treas Bil (VBIL)
Ishares Tr Rus 1000 Etf (IWB)
Ishares Tr 0-3 Mnth Treasry (SGOV)

View all positions for Tower Research Capital

Top funds holding Pelthos Therapeutics

Murchinson
Vanguard Group
Ikarian Capital
Boothbay Fund Management
Diadema Partners
Geode Capital Management
Knott David M Jr
Steward Partners Investment Advisory
Tower Research Capital
UBS Group
Jpmorgan Chase & Co

View all funds holding Pelthos Therapeutics